“Advancements in PCR Technology and Growing Application Areas”
- Real-time PCR has become the gold standard in various diagnostic and research applications due to its ability to provide quantitative data. The growing use of real-time PCR in clinical diagnostics, especially for genetic testing and cancer detection, is significantly contributing to market growth.
- For instance, in 2024, the European Medicines Agency (EMA) approved a real-time PCR-based diagnostic developed by Qiagen for identifying EGFR mutations in non-small cell lung cancer, supporting targeted therapy decisions across EU countries.
- With the growing trend of personalized medicine, PCR devices are being used to tailor treatments based on an individual’s genetic makeup, particularly in oncology and genetic disorders.
